Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
240
NCT01934634
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer
Phase: Phase 1
Role: Collaborator
Start: Mar 31, 2014
Completion: Not specified
NCT05040633
The ECEALT Chronic Low Back Pain Study
Phase: N/A
Role: Lead Sponsor
Start: Oct 1, 2022
Completion: Apr 30, 2024